These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17133848)

  • 1. Clinical characteristics and outcomes of Chinese patients with cholesterol crystal embolism after coronary intervention.
    Meng L; Huo Y; Ho W; Liu ZP
    Clin Cardiol; 2006 Nov; 29(11):503-5. PubMed ID: 17133848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of corticosteroids in the treatment of cholesterol crystal embolism after cardiac catheterization: a report of four Japanese cases.
    Masuda J; Tanigawa T; Nakamori S; Sawai T; Murata T; Ishikawa E; Yamada N; Nakamura M; Ito M
    Intern Med; 2013; 52(9):993-8. PubMed ID: 23648720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of cholesterol embolism confirmed by skin biopsy and successfully treated with statins and steroids.
    Matsumura T; Matsumoto A; Ohno M; Suzuki S; Ohta M; Suzuki E; Takenaka K; Hirata Y; Fujita T; Nagai R
    Am J Med Sci; 2006 May; 331(5):280-3. PubMed ID: 16702800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism.
    Nakayama M; Nagata M; Hirano T; Sugai K; Katafuchi R; Imayama S; Uesugi N; Tsuchihashi T; Kumagai H
    Clin Nephrol; 2006 Oct; 66(4):232-9. PubMed ID: 17063989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.
    Kastelein JJ; Isaacsohn JL; Ose L; Hunninghake DB; Frohlich J; Davidson MH; Habib R; Dujovne CA; Crouse JR; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB
    Am J Cardiol; 2000 Jul; 86(2):221-3. PubMed ID: 10913488
    [No Abstract]   [Full Text] [Related]  

  • 6. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
    Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
    Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure.
    Scolari F; Bracchi M; Valzorio B; Movilli E; Costantino E; Savoldi S; Zorat S; Bonardelli S; Tardanico R; Maiorca R
    Nephrol Dial Transplant; 1996 Aug; 11(8):1607-12. PubMed ID: 8856220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol crystal embolization (CCE): Improvement of renal function with high-dose corticosteroid treatment.
    Desai M; Ram R; Prayaga A; Dakshinamurty KV
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):327-30. PubMed ID: 21422636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
    Shukla A; Sharma MK; Jain A; Goel PK
    Indian Heart J; 2005; 57(6):675-80. PubMed ID: 16521637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study].
    März W
    MMW Fortschr Med; 2003 Dec; 145(50):46-9. PubMed ID: 14963971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal atheroembolic disease: evaluation of the efficacy of corticosteroid therapy].
    Stabellini N; Cerretani D; Russo G; Rizzioli E; Gilli P
    G Ital Nefrol; 2002; 19(1):18-21. PubMed ID: 12165941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of lipid-modulating drugs in complicated course of coronary heart disease.
    Gratsianskii NA; Vaulin NA
    Bull Exp Biol Med; 2007 Sep; 144(3):438-46. PubMed ID: 18457052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
    Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
    J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and renal function.
    Elisaf M; Mikhailidis DP
    Angiology; 2002; 53(5):493-502. PubMed ID: 12365855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose statins in acute coronary syndromes.
    Davidson MH
    JAMA; 2005 Jan; 293(1):38; author reply 38-9. PubMed ID: 15632331
    [No Abstract]   [Full Text] [Related]  

  • 17. Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.
    Brown AS; Bakker-Arkema RG; Yellen L; Henley RW; Guthrie R; Campbell CF; Koren M; Woo W; McLain R; Black DM
    J Am Coll Cardiol; 1998 Sep; 32(3):665-72. PubMed ID: 9741509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimation.
    Sathyapalan T; Atkin SL; Kilpatrick ES
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):180-2. PubMed ID: 24719214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan.
    Tamura K; Umemura M; Yano H; Sakai M; Sakurai Y; Tsurumi Y; Koide Y; Usui T; Yabana M; Toya Y; Tokita Y; Umemura S
    Clin Exp Nephrol; 2003 Mar; 7(1):67-71. PubMed ID: 14586747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.